{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:19:14Z","timestamp":1792016354661,"version":"4.4.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/13778-8"],"award-info":[{"award-number":["2016\/13778-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bcp.2023.115684","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T03:48:20Z","timestamp":1689565700000},"page":"115684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["MMP-2 and its implications on cardiac function and structure: Interplay with inflammation in hypertension"],"prefix":"10.1016","volume":"215","author":[{"given":"Tha\u00eds","family":"Ribeiro Vitorino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Ferraz do Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefany","family":"Bruno de Assis Cau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3823-8845","authenticated-orcid":false,"given":"Elen","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1186\/s12889-022-13271-0","article-title":"Global, regional, and national burden of hypertensive heart disease during 1990\u20132019: an analysis of the global burden of disease study 2019","volume":"22","author":"Lu","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bcp.2023.115684_b0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.freeradbiomed.2018.11.002","article-title":"Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects","volume":"130","author":"Rizzi","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10.1016\/j.bcp.2023.115684_b0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardfail.2010.02.005","article-title":"Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension","volume":"16","author":"Rizzi","year":"2010","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2011.08.060","article-title":"Tempol inhibits TGF-\u03b2 and MMPs upregulation and prevents cardiac hypertensive changes","volume":"165","author":"Rizzi","year":"2013","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/bcpt.12400","article-title":"The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension","volume":"117","author":"Cau","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.CIR.92.4.805","article-title":"Left ventricular hypertrophy has a greater impact on survival in women than in men","volume":"92","author":"Liao","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2006.01.077","article-title":"Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure","volume":"48","author":"L\u00f3pez","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.bcp.2023.115684_b0050","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00004872-199816070-00018","article-title":"Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans","volume":"16","author":"Rossi","year":"1998","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0055","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.64.6.1041","article-title":"Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle","volume":"64","author":"Jalil","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2023.115684_b0060","first-page":"12","article-title":"Alterations in the extracellular matrix of the myocardium in essential hypertension","author":"Pardo Mind\u00e1n","year":"1993","journal-title":"Eur Heart J 14 Suppl J"},{"issue":"12","key":"10.1016\/j.bcp.2023.115684_b0065","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1113\/JP273043","article-title":"Hypertension-induced remodelling: on the interactions of cardiac risk factors","volume":"595","author":"Tomek","year":"2017","journal-title":"J Physiol"},{"issue":"10","key":"10.1016\/j.bcp.2023.115684_b0070","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajh\/3.10.735","article-title":"Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis","volume":"3","author":"McLenachan","year":"1990","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.bcp.2023.115684_b0075","doi-asserted-by":"crossref","first-page":"H1015","DOI":"10.1152\/ajpheart.00023.2006","article-title":"Cardiac fibroblasts: friend or foe?","volume":"291","author":"Baudino","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/01.HYP.0000025443.61926.12","article-title":"Norepinephrine enhances fibrosis mediated by TGF-beta in cardiac fibroblasts","volume":"40","author":"Akiyama-Uchida","year":"2002","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.bcp.2023.115684_b0085","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.101.10.1130","article-title":"Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts","volume":"101","author":"Kawano","year":"2000","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bcp.2023.115684_b0090","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","article-title":"Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation","volume":"106","author":"Leask","year":"2010","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0095","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2023.115684_b0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yjmcc.2015.11.002","article-title":"Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)","volume":"94","author":"Turner","year":"2016","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0105","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/HYPERTENSIONAHA.107.093120","article-title":"Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension","volume":"50","author":"Salles","year":"2007","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/HYPERTENSIONAHA.109.142042","article-title":"Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart","volume":"55","author":"Levick","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.bcp.2023.115684_b0115","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1172\/JCI22304","article-title":"Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice","volume":"115","author":"Matsumura","year":"2005","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.HYP.0000144400.49062.6b","article-title":"Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone","volume":"44","author":"Chen","year":"2004","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0125","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1073\/pnas.48.6.1014","article-title":"Collagenolytic activity in amphibian tissues: a tissue culture assay","volume":"48","author":"Gross","year":"1962","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0006-291X(75)90573-2","article-title":"Inhibition of human collagenase activity by a small molecular weight serum protein","volume":"66","author":"Woolley","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.bcp.2023.115684_b0135","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"24","key":"10.1016\/j.bcp.2023.115684_b0140","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1111\/febs.15701","article-title":"Multifunctional intracellular matrix metalloproteinases: implications in disease","volume":"288","author":"Bassiouni","year":"2021","journal-title":"Febs j"},{"key":"10.1016\/j.bcp.2023.115684_b0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","article-title":"Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease","volume":"81","author":"Wang","year":"2018","journal-title":"Adv Pharmacol"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.0000013290.12884.A3","article-title":"Matrix metalloproteinases: regulation and dysregulation in the failing heart","volume":"90","author":"Spinale","year":"2002","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/bcpt.12282","article-title":"Matrix metalloproteinases are involved in cardiovascular diseases","volume":"115","author":"Azevedo","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1183\/09031936.00146510","article-title":"Series \u201cmatrix metalloproteinases in lung health and disease\u201d: Biological role of matrix metalloproteinases: a critical balance","volume":"38","author":"L\u00f6ffek","year":"2011","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0165","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrd2308","article-title":"Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases","volume":"6","author":"Hu","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000477785","article-title":"Matrix Metalloproteases in Arterial Hypertension and their Trend after Antihypertensive Treatment","volume":"42","author":"Hopps","year":"2017","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0175","doi-asserted-by":"crossref","first-page":"e34177","DOI":"10.1371\/journal.pone.0034177","article-title":"A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity","volume":"7","author":"Lovett","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2023.115684_b0180","doi-asserted-by":"crossref","unstructured":"Q. Shen, E.S. Lee, R.L. Pitts, M.H. Wu, S.Y. Yuan, Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells, Mol Cancer Res 8(7) (2010) 939-51.","DOI":"10.1158\/1541-7786.MCR-09-0523"},{"issue":"19","key":"10.1016\/j.bcp.2023.115684_b0185","doi-asserted-by":"crossref","first-page":"14033","DOI":"10.1016\/S0021-9258(19)85205-5","article-title":"Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2","volume":"268","author":"Strongin","year":"1993","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.bcp.2023.115684_b0190","first-page":"2572","article-title":"Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro","volume":"98","author":"Rajagopalan","year":"1996","journal-title":"Implications for atherosclerotic plaque stability, J Clin Invest"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0195","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bcp.2008.11.004","article-title":"Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione","volume":"77","author":"Viappiani","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10.1016\/j.bcp.2023.115684_b0200","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.CIR.0000028818.33488.7B","article-title":"Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury","volume":"106","author":"Wang","year":"2002","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.bcp.2023.115684_b0205","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1161\/CIRCULATIONAHA.109.930222","article-title":"Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia\/reperfusion injury","volume":"122","author":"Ali","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0210","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.104.531616","article-title":"Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2","volume":"112","author":"Sawicki","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0215","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.yjmcc.2007.07.055","article-title":"Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury","volume":"43","author":"Sung","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.bcp.2023.115684_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114744","article-title":"MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin","volume":"193","author":"Parente","year":"2021","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.bcp.2023.115684_b0225","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1002\/jcp.24040","article-title":"Mechanisms of cytosolic targeting of matrix metalloproteinase-2","volume":"227","author":"Ali","year":"2012","journal-title":"J Cell Physiol"},{"issue":"7","key":"10.1016\/j.bcp.2023.115684_b0230","doi-asserted-by":"crossref","first-page":"e68154","DOI":"10.1371\/journal.pone.0068154","article-title":"N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure","volume":"8","author":"Lovett","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2012.10.010","article-title":"Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-\u03b2 in renovascular hypertension-induced cardiac hypertrophy","volume":"94","author":"Rizzi","year":"2013","journal-title":"Exp Mol Pathol"},{"issue":"14","key":"10.1016\/j.bcp.2023.115684_b0240","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/cvr\/cvx115","article-title":"Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury","volume":"113","author":"Barhoumi","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2023.115684_b0245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.redox.2018.07.005","article-title":"Matrix metalloproteinase-2-induced epidermal growth factor receptor transactivation impairs redox balance in vascular smooth muscle cells and facilitates vascular contraction","volume":"18","author":"Prado","year":"2018","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.110.159525","article-title":"MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE","volume":"57","author":"Odenbach","year":"2011","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.bcp.2023.115684_b0255","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/01.RES.85.10.906","article-title":"Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor","volume":"85","author":"Fernandez-Patron","year":"1999","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.bcp.2023.115684_b0260","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.RES.87.8.670","article-title":"Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction","volume":"87","author":"Fernandez-Patron","year":"2000","journal-title":"Circ Res"},{"issue":"Pt. 3","key":"10.1016\/j.bcp.2023.115684_b0265","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20040920","article-title":"Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator","volume":"383","author":"Mart\u00ednez","year":"2004","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0270","doi-asserted-by":"crossref","first-page":"H1847","DOI":"10.1152\/ajpheart.00434.2006","article-title":"Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction","volume":"292","author":"Bergman","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0275","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12265-013-9528-2","article-title":"Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis","volume":"7","author":"Hendry","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0280","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cardfail.2003.11.003","article-title":"Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction","volume":"10","author":"Squire","year":"2004","journal-title":"J Card Fail"},{"issue":"3","key":"10.1016\/j.bcp.2023.115684_b0285","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ahj.2004.11.016","article-title":"Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure","volume":"150","author":"George","year":"2005","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0290","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.108.844324","article-title":"Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers","volume":"3","author":"Biolo","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0295","first-page":"315","article-title":"Metalloproteinases-2 and -9 predict left ventricular remodeling after myocardial infarction","volume":"100","author":"Cogni","year":"2013","journal-title":"Arq Bras Cardiol"},{"issue":"8","key":"10.1016\/j.bcp.2023.115684_b0300","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/ph15080920","article-title":"Matrix Metalloproteinase 2 as a Pharmacological Target in Heart Failure","volume":"15","author":"Gon\u00e7alves","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0305","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/iub.594","article-title":"Regulation of myocardial matrix metalloproteinase expression and activity by cardiac fibroblasts","volume":"64","author":"Turner","year":"2012","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0310","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/j.2040-4603.2015.tb00629.x","article-title":"Cardiac fibroblast physiology and pathology","volume":"5","author":"Dostal","year":"2015","journal-title":"Compr Physiol"},{"issue":"3","key":"10.1016\/j.bcp.2023.115684_b0315","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","article-title":"Revisiting Cardiac Cellular Composition","volume":"118","author":"Pinto","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0320","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2613.2010.00744.x","article-title":"Transgenic expression of matrix metalloproteinase-2 induces coronary artery ectasia","volume":"92","author":"Dahi","year":"2011","journal-title":"Int J Exp Pathol"},{"issue":"12","key":"10.1016\/j.bcp.2023.115684_b0325","first-page":"2028","article-title":"Hypertension: a new treatment for an old disease?","volume":"176","author":"Bomfim","year":"2019","journal-title":"Targeting the immune system, Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0330","first-page":"257","article-title":"Passive transfer of autoimmune induced hypertension in the rat by lymph node cells","volume":"25","author":"Okuda","year":"1967","journal-title":"Tex Rep Biol Med"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0335","first-page":"199","article-title":"Influence of neonatal thymectomy on blood pressure and hypertensive vascular disease in rats with renal hypertension","volume":"83","author":"Svendsen","year":"1975","journal-title":"Acta Pathol Microbiol Scand A"},{"issue":"10","key":"10.1016\/j.bcp.2023.115684_b0340","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0345","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/HYPERTENSIONAHA.115.05779","article-title":"Obligatory Role for B Cells in the Development of Angiotensin II-Dependent Hypertension","volume":"66","author":"Chan","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0350","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2007.07.003","article-title":"Matrix metalloproteinases as modulators of inflammation","volume":"19","author":"Manicone","year":"2008","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0355","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster","year":"2015","journal-title":"Circ Res"},{"issue":"7838","key":"10.1016\/j.bcp.2023.115684_b0360","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvi\u0148ukov\u00e1","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115684_b0365","article-title":"Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0370","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/HYPERTENSIONAHA.113.02843","article-title":"S100a8\/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury","volume":"63","author":"Wu","year":"2014","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.bcp.2023.115684_b0375","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/CIRCULATIONAHA.111.034470","article-title":"Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction","volume":"124","author":"Wenzel","year":"2011","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.bcp.2023.115684_b0380","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1111\/febs.15803","article-title":"Roles of neutrophil granule proteins in orchestrating inflammation and immunity","volume":"289","author":"Othman","year":"2022","journal-title":"Febs j"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0385","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/jsre.1998.5294","article-title":"Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2","volume":"76","author":"Schwartz","year":"1998","journal-title":"J Surg Res"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0390","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jcp.10014","article-title":"Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis","volume":"189","author":"Shamamian","year":"2001","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0395","first-page":"1575","article-title":"Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)","volume":"11","author":"McCarthy","year":"2021","journal-title":"Compr Physiol"},{"issue":"7","key":"10.1016\/j.bcp.2023.115684_b0400","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/annrheumdis-2013-204837","article-title":"Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2","volume":"74","author":"Carmona-Rivera","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0405","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0410","doi-asserted-by":"crossref","first-page":"H1301","DOI":"10.1152\/ajpheart.00566.2019","article-title":"Pharmacological blockage of ICAM-1 improves angiotensin II-induced cardiac remodeling by inhibiting adhesion of LFA-1(+) monocytes","volume":"317","author":"Lin","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.bcp.2023.115684_b0415","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijcard.2015.10.126","article-title":"Macrophages dictate the progression and manifestation of hypertensive heart disease","volume":"203","author":"Kain","year":"2016","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.bcp.2023.115684_b0420","doi-asserted-by":"crossref","first-page":"165551","DOI":"10.1016\/j.bbadis.2019.165551","article-title":"Chronic inhibition of chemokine receptor CXCR2 attenuates cardiac remodeling and dysfunction in spontaneously hypertensive rats","volume":"1865","author":"Zhang","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"9","key":"10.1016\/j.bcp.2023.115684_b0425","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.3390\/molecules23092124","article-title":"Exogenous Heat Shock Cognate Protein 70 Suppresses LPS-Induced Inflammation by Down-Regulating NF-\u03baB through MAPK and MMP-2\/-9 Pathways in Macrophages","volume":"23","author":"Sulistyowati","year":"2018","journal-title":"Molecules"},{"issue":"22","key":"10.1016\/j.bcp.2023.115684_b0430","doi-asserted-by":"crossref","first-page":"19027","DOI":"10.1074\/jbc.M009562200","article-title":"Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation","volume":"276","author":"Shankavaram","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0435","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11307-015-0882-0","article-title":"Distribution of Matrix Metalloproteinases in Human Atherosclerotic Carotid Plaques and Their Production by Smooth Muscle Cells and Macrophage Subsets","volume":"18","author":"Jager","year":"2016","journal-title":"Mol Imaging Biol"},{"issue":"8","key":"10.1016\/j.bcp.2023.115684_b0440","doi-asserted-by":"crossref","first-page":"e42507","DOI":"10.1371\/journal.pone.0042507","article-title":"Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-\u03baB","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0445","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/HYPERTENSIONAHA.108.123158","article-title":"Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart","volume":"53","author":"Levick","year":"2009","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.bcp.2023.115684_b0450","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/00004872-200310000-00022","article-title":"A role for cardiac mast cells in the pathogenesis of hypertensive heart disease","volume":"21","author":"Shiota","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.bcp.2023.115684_b0455","doi-asserted-by":"crossref","unstructured":"C. Yang, J. Li, Z. Deng, S. Luo, J. Liu, W. Fang, F. Liu, T. Liu, X. Zhang, Y. Zhang, Z. Meng, S. Zhang, J. Luo, C. Liu, D. Yang, L. Liu, G.K. Sukhova, A. Sadybekov, V. Katritch, P. Libby, J. Wang, J. Guo, G.P. Shi, Eosinophils protect pressure overload- and \u03b2-adrenoreceptor agonist-induced cardiac hypertrophy, Cardiovasc Res (2022).","DOI":"10.1093\/cvr\/cvac060"},{"key":"10.1016\/j.bcp.2023.115684_b0460","doi-asserted-by":"crossref","unstructured":"K. Kumagai, I. Ohno, S. Okada, Y. Ohkawara, K. Suzuki, T. Shinya, H. Nagase, K. Iwata, K. Shirato, Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma, J Immunol 162(7) (1999) 4212-9.","DOI":"10.4049\/jimmunol.162.7.4212"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0465","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000371419","article-title":"Inhibition of MMP-2-Mediated Mast Cell Invasion by NF-\u03baB Inhibitor DHMEQ in Mast Cells","volume":"166","author":"Noma","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"issue":"9","key":"10.1016\/j.bcp.2023.115684_b0470","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.4049\/jimmunol.162.9.5528","article-title":"Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta","volume":"162","author":"Fang","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0475","doi-asserted-by":"crossref","first-page":"L236","DOI":"10.1152\/ajplung.90462.2008","article-title":"MMP dependence of fibroblast contraction and collagen production induced by human mast cell activation in a three-dimensional collagen lattice","volume":"296","author":"Margulis","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bcp.2023.115684_b0480","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3389\/fimmu.2018.02163","article-title":"Role of Matrix Metalloproteinase-2 in Eosinophil-Mediated Airway Remodeling","volume":"9","author":"Kuwabara","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0485","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/01.HYP.0000227247.27111.b2","article-title":"Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling","volume":"48","author":"Yu","year":"2006","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0490","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2023.115684_b0495","doi-asserted-by":"crossref","unstructured":"F. Ma, J. Feng, C. Zhang, Y. Li, G. Qi, H. Li, Y. Wu, Y. Fu, Y. Zhao, H. Chen, J. Du, H. Tang, The requirement of CD8+ T cells to initiate and augment acute cardiac inflammatory response to high blood pressure, J Immunol 192(7) (2014) 3365-73.","DOI":"10.4049\/jimmunol.1301522"},{"issue":"7","key":"10.1016\/j.bcp.2023.115684_b0500","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1172\/JCI97490","article-title":"Nox2 in regulatory T cells promotes angiotensin II-induced cardiovascular remodeling","volume":"128","author":"Emmerson","year":"2018","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0505","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12865-021-00406-y","article-title":"CD100 modulates cytotoxicity of CD8(+) T cells in patients with acute myocardial infarction","volume":"22","author":"Li","year":"2021","journal-title":"BMC Immunol"},{"key":"10.1016\/j.bcp.2023.115684_b0510","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fphys.2018.01581","article-title":"SGK1-FoxO1 Signaling Pathway Mediates Th17\/Treg Imbalance and Target Organ Inflammation in Angiotensin II-Induced Hypertension","volume":"9","author":"Du","year":"2018","journal-title":"Front Physiol"},{"issue":"22","key":"10.1016\/j.bcp.2023.115684_b0515","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/CIRCULATIONAHA.108.832782","article-title":"Regulatory T cells ameliorate angiotensin II-induced cardiac damage","volume":"119","author":"Kvakan","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0520","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.yexmp.2011.04.003","article-title":"Lentivirus mediated IL-17R blockade improves diastolic cardiac function in spontaneously hypertensive rats","volume":"91","author":"Liu","year":"2011","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0525","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002484","article-title":"Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis","volume":"5","author":"Cordero-Reyes","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.bcp.2023.115684_b0530","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2021.05.003","article-title":"B cells modulate the expression of MHC-II on cardiac CCR2(-) macrophages","volume":"157","author":"Rocha-Resende","year":"2021","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0535","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1165\/rcmb.2010-0125OC","article-title":"Endogenous matrix metalloproteinases 2 and 9 regulate activation of CD4+ and CD8+ T cells","volume":"44","author":"Benson","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0540","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2567.2007.02728.x","article-title":"Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages","volume":"124","author":"Oviedo-Orta","year":"2008","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0545","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/cvr\/cvy164","article-title":"CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice","volume":"115","author":"Wang","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0550","first-page":"269","article-title":"Matrix metalloproteinases of human NK cells","volume":"14","author":"Albertsson","year":"2000","journal-title":"In Vivo"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0555","first-page":"593","article-title":"A high concentration of MMP-2\/gelatinase A and MMP-9\/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line","volume":"22","author":"Lee","year":"2008","journal-title":"In Vivo"},{"issue":"3","key":"10.1016\/j.bcp.2023.115684_b0560","first-page":"335","article-title":"Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations","volume":"14","author":"Castro","year":"2013","journal-title":"Curr Drug Targets"},{"issue":"24","key":"10.1016\/j.bcp.2023.115684_b0565","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bcp.2023.115684_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114121","article-title":"TNF-\u03b1 inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure","volume":"180","author":"Mattos","year":"2020","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10.1016\/j.bcp.2023.115684_b0575","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.RES.86.12.1259","article-title":"Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro","volume":"86","author":"Siwik","year":"2000","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0580","doi-asserted-by":"crossref","first-page":"H1332","DOI":"10.1152\/ajpheart.00198.2018","article-title":"MMP-2: is too low as bad as too high in the cardiovascular system?","volume":"315","author":"Hardy","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"10.1016\/j.bcp.2023.115684_b0585","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1002\/art.24959","article-title":"Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation","volume":"60","author":"Guma","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0590","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.119.13642","article-title":"Effects of Interleukin-1\u03b2 Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk: A Secondary Analysis of CANTOS","volume":"75","author":"Rothman","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0595","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/HYPERTENSIONAHA.119.13982","article-title":"IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1-7]) and Decreases Blood Pressure in Obese Individuals","volume":"75","author":"Urwyler","year":"2020","journal-title":"Hypertension"},{"issue":"16","key":"10.1016\/j.bcp.2023.115684_b0600","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168639","article-title":"Interleukin-1\u03b2 in Multifactorial Hypertension: Inflammation, Vascular Smooth Muscle Cell and Extracellular Matrix Remodeling, and Non-Coding RNA Regulation","volume":"22","author":"Melton","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.bcp.2023.115684_b0605","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1161\/01.CIR.97.14.1375","article-title":"Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha","volume":"97","author":"Bryant","year":"1998","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0610","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","article-title":"Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha","volume":"81","author":"Kubota","year":"1997","journal-title":"Circ Res"},{"issue":"9507","key":"10.1016\/j.bcp.2023.115684_b0615","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodelling","volume":"367","author":"Opie","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2023.115684_b0620","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.redox.2016.06.004","article-title":"A biphasic effect of TNF-\u03b1 in regulation of the Keap1\/Nrf2 pathway in cardiomyocytes","volume":"9","author":"Shanmugam","year":"2016","journal-title":"Redox Biol"},{"issue":"9","key":"10.1016\/j.bcp.2023.115684_b0625","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nm.3925","article-title":"Tumor necrosis factor-\u03b1 confers cardioprotection through ectopic expression of keratins K8 and K18","volume":"21","author":"Papathanasiou","year":"2015","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.bcp.2023.115684_b0630","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11886-018-1067-7","article-title":"Tumor Necrosis Factor-\u03b1 in Heart Failure: an Updated Review","volume":"20","author":"Schumacher","year":"2018","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"10.1016\/j.bcp.2023.115684_b0635","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.3390\/jcm9103267","article-title":"Complexity of TNF-\u03b1 Signaling in Heart Disease","volume":"9","author":"Rolski","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0640","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cellsig.2012.02.006","article-title":"Signal transduction by tumor necrosis factor receptors","volume":"24","author":"Cabal-Hierro","year":"2012","journal-title":"Cell Signal"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0645","doi-asserted-by":"crossref","first-page":"C779","DOI":"10.1152\/ajpcell.00398.2003","article-title":"Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha","volume":"286","author":"Arenas","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"10.1016\/j.bcp.2023.115684_b0650","doi-asserted-by":"crossref","first-page":"e0138372","DOI":"10.1371\/journal.pone.0138372","article-title":"Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress","volume":"10","author":"Sriramula","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0655","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.molcel.2007.04.021","article-title":"TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death","volume":"26","author":"Kim","year":"2007","journal-title":"Mol Cell"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0660","doi-asserted-by":"crossref","first-page":"e35506","DOI":"10.1371\/journal.pone.0035506","article-title":"Reciprocal interaction between macrophages and T cells stimulates IFN-\u03b3 and MCP-1 production in Ang II-induced cardiac inflammation and fibrosis","volume":"7","author":"Han","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0665","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.112.199265","article-title":"Interferon-\u03b3 signaling inhibition ameliorates angiotensin II-induced cardiac damage","volume":"60","author":"Mark\u00f3","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0670","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0008-6363(02)00719-8","article-title":"Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction","volume":"57","author":"Gao","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0675","doi-asserted-by":"crossref","first-page":"H587","DOI":"10.1152\/ajpheart.00298.2012","article-title":"Interferon-\u03b3 ablation exacerbates myocardial hypertrophy in diastolic heart failure","volume":"303","author":"Garcia","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0680","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10741-013-9393-8","article-title":"Could interferon-gamma be a therapeutic target for treating heart failure?","volume":"19","author":"Levick","year":"2014","journal-title":"Heart Fail Rev"},{"issue":"9","key":"10.1016\/j.bcp.2023.115684_b0685","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.autrev.2017.07.009","article-title":"Effects of Interleukin 17 on the cardiovascular system","volume":"16","author":"Robert","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bcp.2023.115684_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.06.016","article-title":"Interleukin 17A in atherosclerosis - Regulation and pathophysiologic effector function","volume":"122","author":"Nordlohne","year":"2019","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.bcp.2023.115684_b0695","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/CS20190682","article-title":"Interleukin-17A induces vascular remodeling of small arteries and blood pressure elevation","volume":"134","author":"Orejudo","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0700","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.bcp.2023.115684_b0705","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/ATVBAHA.114.304108","article-title":"Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease","volume":"34","author":"Karbach","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.bcp.2023.115684_b0710","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.109.213157","article-title":"Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy","volume":"106","author":"Baldeviano","year":"2010","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.bcp.2023.115684_b0715","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11906-021-01128-7","article-title":"Interleukin 17A: Key Player in the Pathogenesis of Hypertension and a Potential Therapeutic Target","volume":"23","author":"Davis","year":"2021","journal-title":"Curr Hypertens Rep"},{"issue":"12","key":"10.1016\/j.bcp.2023.115684_b0720","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/bph.14359","article-title":"Salt, inflammation, IL-17 and hypertension","volume":"176","author":"Wenzel","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2023.115684_b0725","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1074\/jbc.M308809200","article-title":"Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT\/enhancer-binding protein family members","volume":"279","author":"Ruddy","year":"2004","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0730","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0735","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.atherosclerosis.2007.06.033","article-title":"Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study","volume":"197","author":"Lakoski","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bcp.2023.115684_b0740","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cca.2019.05.006","article-title":"Association of IL-10 to coronary disease severity in patients with metabolic syndrome","volume":"495","author":"Barcelos","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.bcp.2023.115684_b0745","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.20171274","article-title":"Cardiac macrophages promote diastolic dysfunction","volume":"215","author":"Hulsmans","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2023.115684_b0750","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.559220","article-title":"Signaling via the Interleukin-10 Receptor Attenuates Cardiac Hypertrophy in Mice During Pressure Overload, but not Isoproterenol Infusion","volume":"11","author":"Stafford","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bcp.2023.115684_b0755","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.lfs.2016.01.022","article-title":"Interleukin-10 deficiency aggravates angiotensin II-induced cardiac remodeling in mice","volume":"146","author":"Kwon","year":"2016","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.bcp.2023.115684_b0760","doi-asserted-by":"crossref","first-page":"F359","DOI":"10.1152\/ajprenal.00206.2020","article-title":"IL-10 treatment decreases blood pressure in male, but not female, spontaneously hypertensive rats","volume":"319","author":"Gillis","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.bcp.2023.115684_b0765","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz Jel","year":"2002","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.bcp.2023.115684_b0770","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/labinvest.2016.52","article-title":"Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-\u03b2","volume":"96","author":"Khan","year":"2016","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.bcp.2023.115684_b0775","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cellsig.2012.10.003","article-title":"TGF-\u03b2 signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities","volume":"25","author":"Samarakoon","year":"2013","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.bcp.2023.115684_b0780","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1634\/stemcells.2004-0354","article-title":"Activation of transforming growth factor-beta1\/p38\/Smad3 signaling in stromal cells requires reactive oxygen species-mediated MMP-2 activity during bone marrow damage","volume":"23","author":"Wang","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.bcp.2023.115684_b0785","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: A perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox Biol"},{"issue":"7","key":"10.1016\/j.bcp.2023.115684_b0790","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.ATV.0000225777.58488.f2","article-title":"Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall","volume":"26","author":"Wang","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:46:21Z","timestamp":1757771181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223002757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":158,"alternative-id":["S0006295223002757"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115684","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MMP-2 and its implications on cardiac function and structure: Interplay with inflammation in hypertension","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115684"}}